The anticipatory effects of Medicare Part D on drug utilization
The anticipatory effects of Medicare Part D on drug utilization
复制标题
DOI：
10.1016/j.jhealeco.2016.06.004
复制
发表时间：
2016-09-01
影响因子：
3.5
通讯作者：
Alpert, Abby
中科院分区：
文献类型：
--
作者：
Alpert, Abby
虽然医疗保健政策经常在实施之前就签署成为法律，但大多数实证研究都忽略了这种滞后。本文论证了医疗保险 D 部分（处方药福利在签署成为法律两年后生效）背景下实施滞后的重要性。利用慢性药物和急性药物对预期未来价格的不同反应，我表明，在预期 D 部分实施的情况下，个人减少了慢性药物的使用，但没有减少急性药物的使用。考虑到这种预期反应，大大降低了 D 部分的估计总治疗效果。(C) 2016 Elsevier B.V. 保留所有权利。
While health care policies are frequently signed into law well before they are implemented, such lags are ignored in most empirical work. This paper demonstrates the importance of implementation lags in the context of Medicare Part D, the prescription drug benefit that took effect two years after it was signed into law. Exploiting the differential responses of chronic and acute drugs to anticipated future prices, I show that individuals reduced drug utilization for chronic but not acute drugs in anticipation of Part D's implementation. Accounting for this anticipatory response substantially reduces the estimated total treatment effect of Part D. (C) 2016 Elsevier B.V. All rights reserved.